Literature DB >> 25737492

[Psychotherapeutic and psychosocial interventions in cancer].

P Herschbach1.   

Abstract

Every cancer patient and also other family members should have the chance to utilize psychosocial support facilities. Nowadays, there are well-defined data for estimating the needs for psychosocial support measures and also empirical evidence demonstrating the effectiveness of the most important psychotherapeutic interventions. However, the implementation of these measures within the healthcare system still has many difficulties. The reasons for this are the complexity and the problems to identify those patients who are in need of psychotherapeutic support. Therefore, there are national and international recommendations to screen every individual cancer patient for psychosocial distress and unmet support needs. The presence of a psychiatric diagnosis is not a sufficient criterion. The most important interventions vary between psychoeducation and supplying information, counseling and psychotherapy. In psychotherapy supportive-expressive as well as cognitive-behavioral interventions have proved their value. Of increasing importance are time-limited (approximately 10 sessions) interventions focusing on specific problems, e.g. fear of disease progression or interventions within palliative care.

Entities:  

Mesh:

Year:  2015        PMID: 25737492     DOI: 10.1007/s00115-014-4153-0

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  13 in total

Review 1.  Efficacy of psychosocial interventions in cancer care: evidence is weaker than it first looks.

Authors:  James C Coyne; Stephen J Lepore; Steven C Palmer
Journal:  Ann Behav Med       Date:  2006-10

2.  The NCCN guideline for distress management: a case for making distress the sixth vital sign.

Authors:  Jimmie C Holland; Barry D Bultz
Journal:  J Natl Compr Canc Netw       Date:  2007-01       Impact factor: 11.908

3.  Mindfulness-based stress reduction and cancer: a meta-analysis.

Authors:  Dianne Ledesma; Hiroaki Kumano
Journal:  Psychooncology       Date:  2009-06       Impact factor: 3.894

4.  Effect of psychosocial treatment on survival of patients with metastatic breast cancer.

Authors:  D Spiegel; J R Bloom; H C Kraemer; E Gottheil
Journal:  Lancet       Date:  1989-10-14       Impact factor: 79.321

5.  Patient versus clinician symptom reporting: how accurate is the detection of distress in the oncologic after-care?

Authors:  Andreas Werner; Caroline Stenner; Joachim Schüz
Journal:  Psychooncology       Date:  2011-05-04       Impact factor: 3.894

6.  Supportive-expressive group therapy and distress in patients with metastatic breast cancer: a randomized clinical intervention trial.

Authors:  C Classen; L D Butler; C Koopman; E Miller; S DiMiceli; J Giese-Davis; P Fobair; R W Carlson; H C Kraemer; D Spiegel
Journal:  Arch Gen Psychiatry       Date:  2001-05

7.  Existential behavioural therapy for informal caregivers of palliative patients: a randomised controlled trial.

Authors:  M J Fegg; M Brandstätter; M Kögler; G Hauke; P Rechenberg-Winter; V Fensterer; H Küchenhoff; M Hentrich; C Belka; G D Borasio
Journal:  Psychooncology       Date:  2013-03-27       Impact factor: 3.894

8.  Meaning-centered group psychotherapy for patients with advanced cancer: a pilot randomized controlled trial.

Authors:  William Breitbart; Barry Rosenfeld; Christopher Gibson; Hayley Pessin; Shannon Poppito; Christian Nelson; Alexis Tomarken; Anne Kosinski Timm; Amy Berg; Colleen Jacobson; Brooke Sorger; Jennifer Abbey; Megan Olden
Journal:  Psychooncology       Date:  2010-01       Impact factor: 3.894

9.  Evaluation of two group therapies to reduce fear of progression in cancer patients.

Authors:  Peter Herschbach; Katrin Book; Andreas Dinkel; Petra Berg; Sabine Waadt; Gabriele Duran; Ursula Engst-Hastreiter; Gerhard Henrich
Journal:  Support Care Cancer       Date:  2009-10-29       Impact factor: 3.603

10.  Four-week prevalence of mental disorders in patients with cancer across major tumor entities.

Authors:  Anja Mehnert; Elmar Brähler; Hermann Faller; Martin Härter; Monika Keller; Holger Schulz; Karl Wegscheider; Joachim Weis; Anna Boehncke; Bianca Hund; Katrin Reuter; Matthias Richard; Susanne Sehner; Sabine Sommerfeldt; Carina Szalai; Hans-Ulrich Wittchen; Uwe Koch
Journal:  J Clin Oncol       Date:  2014-10-06       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.